NTF Statement on USDA Approving Additional Importation of Modified Live Avian Metapneumovirus (aMPV) Vaccines
WASHINGTON – The National Turkey Federation (NTF) issued the following statement on the U.S. Department of Agriculture’s (USDA) decision to authorize importation of additional commercial modified live avian metapneumovirus (aMPV) vaccines:
“The National Turkey Federation (NTF) applauds USDA’s approval for the importation of additional commercial modified live avian metapneumovirus (aMPV) vaccines. This milestone further reflects our industry’s commitment to safeguarding the health and vitality of U.S. commercial turkey flocks. With these new authorizations, NTF members Vaxxinova, Boehringer Ingelheim and Zoetis Animal Health are ready to introduce the vaccine to the industry, further strengthening our efforts to protect turkey health. We urge USDA to continue its efforts to facilitate the importation and development of additional aMPV vaccines, including the advancement of a domestic vaccine.”